3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Hepatocellular
131
Liver Neoplasms
42
Carcinoma, Renal Cell
36
Leukemia, Myeloid, Acute
32
Neoplasm Metastasis
26
Breast Neoplasms
24
Carcinoma, Non-Small-Cell Lung
22
Kidney Neoplasms
16
Neoplasms
14
Prostatic Neoplasms
12
Pancreatic Neoplasms
12
Recurrence
11
Lung Neoplasms
11
Colorectal Neoplasms
10
Sarcoma
9
Melanoma
9
Brain Neoplasms
9
Myelodysplastic Syndromes
8
Glioblastoma
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia
6
Urinary Bladder Neoplasms
5
Thyroid Neoplasms
5
Rectal Neoplasms
5
Multiple Myeloma
5
Leukemia, Myelomonocytic, Chronic
5
Stomach Neoplasms
4
Ovarian Neoplasms
4
Liver Diseases
4
Gliosarcoma
4
Interventions
Etoposide
19
Carboplatin
19
Ifosfamide
16
Filgrastim
16
Peripheral Blood Stem Cell Transplantation
13
Paclitaxel
13
Cisplatin
12
Cyclophosphamide
10
Thiotepa
7
Therapeutics
5
Radiotherapy
5
Melphalan
5
Busulfan
5
Magnetic Resonance Spectroscopy
4
Gemcitabine
4
Flow Cytometry
4
pegfilgrastim
3
etoposide phosphate
3
Surveys and Questionnaires
3
Psychiatric Rehabilitation
3
Methylprednisolone
3
Methods
3
Immunologic Techniques
3
Granulocyte Colony-Stimulating Factor
3
Epirubicin
3
Dexamethasone
3
Blood Specimen Collection
3
Bleomycin
3
tremelimumab
2
durvalumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Testicular Neoplasms
×
Sorafenib
×
Clear all
NCT00772694
2008-10-24
GCT
Fondation Wygrajmy Zdrowie
Phase 2
Unknown
20 enrolled